FDA's REMS Stronghold: Industry Sees Need For Alternate Risk Management Plans Beyond Mandatory Programs

As Risk Evaluation and Mitigation Strategies become more and more commonplace, industry is starting to balk at the use of the mandatory programs for every risk management activity

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet